Back to 
STATE STREET CORP
STATE STREET CORP
KDNYShowing 0 of 12 quarters
Position history for STATE STREET CORP's holdings in CHINOOK THERAPEUTICS INC
As of its Q2 2023 13F, State Street held 2,907,317 shares of KDNY (Chinook Therapeutics), worth $111.7M. State Street's 13F filings listed KDNY from Q4 2020 to Q2 2023, 11 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of KDNY: BAKER BROS. ADVISORS LP, FARALLON CAPITAL MANAGEMENT, L.L.C., DIMENSIONAL FUND ADVISORS LP